Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · see citing works

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works

The Warburg Effect: How Does it Benefit Cancer Cells?

Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · see citing works

The metabolism of tumors in the body

Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · see citing works

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · see citing works

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,633 · see citing works

Targeting cancer metabolism: a therapeutic window opens

Heiden, M. G. V. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,409 · see citing works

Energy metabolism in tumor cells

Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, Á., & Saavedra, E. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,086 · see citing works

S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding

Hara, M. R., Agrawal, N., Kim, S. F., Cascio, M. B., Fujimuro, M., Ozeki, Y., Takahashi, M., Cheah, J. H., Tankou, S. K., Hester, L. D., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1268 · Cited by 1,071 · see citing works

ABC transporters in cancer: more than just drug efflux pumps

Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2789 · Cited by 1,022 · see citing works

Pyruvate kinase M2 is a phosphotyrosine-binding protein

Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995 · see citing works

Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia

Xu, R., Pelicano, H., Zhou, Y. N., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., & Huang, P. (2005) · Cancer Research · doi:10.1158/0008-5472.613.65.2 · Cited by 835 · see citing works

Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria

Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209603 · Cited by 766 · see citing works

The monocarboxylate transporter family—Role and regulation

Halestrap, A. P., & Wilson, M. C. (2011) · IUBMB Life · doi:10.1002/iub.572 · Cited by 747 · see citing works

Tumor Mitochondria and the Bioenergetics of Cancer Cells

Pedersen, P. L. (2015) · Progress in tumor research · doi:10.1159/000401202 · Cited by 711 · see citing works

The diverse functions of GAPDH: Views from different subcellular compartments

Tristan, C., Shahani, N., Sedlak, T. W., & Sawa, A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.08.003 · Cited by 663 · see citing works

Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy

Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.006 · Cited by 578 · see citing works

Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells

Zhou, Y., Tozzi, F., Chen, J., Fan, F., Xia, L., Wang, J., Gao, G., Zhang, A., Xia, X., Brasher, H., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1674 · Cited by 374 · see citing works

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP

Ko, Y. H., Smith, B. L., Wang, Y., Pomper, M. G., Rini, D. A., Torbenson, M. S., Hullihen, J. M., & Pedersen, P. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.047 · Cited by 352 · see citing works

Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase

Ko, Y. H., Pedersen, P. L., & Geschwind, J. F. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00667-x · Cited by 348 · see citing works

Human pyruvate kinase M2: A multifunctional protein

Gupta, V., & Bamezai, R. N. K. (2010) · Protein Science · doi:10.1002/pro.505 · Cited by 318 · see citing works

Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding.

Bustamante, E., Morris, H. P., & Pedersen, P. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68900-3 · Cited by 315 · see citing works

PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis

Liu, F., Ma, F., Wang, Y., Hao, L., Zeng, H., Jia, C., Wang, Y., Liu, P., Ong, I. M., Li, B., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3630 · Cited by 306 · see citing works

Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase

Messner, K. R., & Imlay, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204958200 · Cited by 301 · cited 1× · see citing works

SLC5A8 , a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers

Li, H., Myeroff, L. L., Smiraglia, D. J., Romero, M. F., Pretlow, T. P., Kasturi, L., Lutterbaugh, J., Rerko, R. M., Casey, G., Issa, J. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1430846100 · Cited by 295 · see citing works

Modulation of type M 2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein

Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., EIGENBRODT, E., & Jansen‐Dürr, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1291 · Cited by 257 · see citing works

Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.

Geschwind, J. F., Ko, Y. H., Torbenson, M. S., Magee, C. A., & Pedersen, P. L. (2002) · PubMed · Cited by 254 · see citing works

Sodium-coupled Monocarboxylate Transporters in Normal Tissues and in Cancer

Ganapathy, V., Thangaraju, M., Gopal, E., Martin, P. M., Itagaki, S., Miyauchi, S., & Prasad, P. D. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9022-y · Cited by 244 · see citing works

Identification of small molecule inhibitors of pyruvate kinase M2

Heiden, M. G. V., Christofk, H. R., Schuman, E., Subtelny, A. O., Sharfi, H., Harlow, E. E., Xian, J., & Cantley, L. C. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.003 · Cited by 239 · see citing works

Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate

Zhao, C., Zhang, H., Lu, W., & Huang, P. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.03.003 · Cited by 230 · see citing works

MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors

Birsoy, K., Wang, T., Possemato, R., Yilmaz, Ö. H., Koch, C. E., Chen, W. W., Hutchins, A., Gültekin, Y., Peterson, T. R., Carette, J. E., et al. (2012) · Nature Genetics · doi:10.1038/ng.2471 · Cited by 226 · see citing works

Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N'-dicyclohexlycarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC

Nakashima, R. A., Mangan, P. S., Colombini, M., & Pedersen, P. L. (1986) · Biochemistry · doi:10.1021/bi00353a010 · Cited by 222 · see citing works

GAPDH as a sensor of NO stress

Hara, M. R., Cascio, M. B., & Sawa, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.01.012 · Cited by 220 · see citing works

Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis

Palmieri, D., Fitzgerald, D. P., Shreeve, S. M., Hua, E., Bronder, J. L., Weil, R. J., Davis, S. R., Stark, A. M., Merino, M. J., Kurek, R., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0234 · Cited by 215 · see citing works

The HK2 Dependent “Warburg Effect” and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate

Lis, P., Dyląg, M., Niedźwiecka, K., Ko, Y. H., Pedersen, P. L., Goffeau, A., & Ułaszewski, S. (2016) · Molecules · doi:10.3390/molecules21121730 · Cited by 201 · see citing works

Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression

Gwak, G., Yoon, J., Kim, K. M., Lee, H.-S., Chung, J. W., & Gores, G. J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.020 · Cited by 188 · see citing works

Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1

Silva, A. P. P. D., El‐Bacha, T., Kyaw, N., dos Santos, R. S., da‐Silva, W. S., Almeida, F. C. L., Poian, A. T. D., & Galina, A. (2008) · Biochemical Journal · doi:10.1042/bj20080805 · Cited by 170 · see citing works

Glycolytic enzyme inhibitors in cancer treatment

Scatena, R., Bottoni, P., Pontoglio, A., Mastrototaro, L., & Giardina, B. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1533 · Cited by 164 · see citing works

A translational study “case report” on the small molecule “energy blocker” 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside

Ko, Y. H., Verhoeven, H. A., Lee, M. J., Corbin, D., Vogl, T. J., & Pedersen, P. L. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9417-4 · Cited by 161 · see citing works

3-bromopyruvate: Targets and outcomes

Shoshan, M. C. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9419-2 · Cited by 144 · see citing works

Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma

Geschwind, J.-F. H., Georgiades, C. S., Ko, Y. H., & Pedersen, P. L. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.3.449 · Cited by 141 · see citing works

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)

Agarwala, S. S., Keilholz, U., Gilles, E. M., Bedikian, A. Y., Wu, J., Kay, R., Stein, C. A., Itri, L. M., Suciu, S., & Eggermont, A. M. M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.016 · Cited by 138 · see citing works

Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug

Cardaci, S., Desideri, E., & Ciriolo, M. R. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9422-7 · Cited by 132 · see citing works

Novel insight into the role of GAPDH playing in tumor

Guo, C., Liu, S., & Sun, M. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0924-x · Cited by 129 · see citing works

3‐Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs

Ihrlund, L. S., Hernlund, E., Khan, O. M., & Shoshan, M. C. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.01.003 · Cited by 124 · see citing works

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death.

Ganapathy‐Kanniappan, S., Geschwind, J.-F. H., Kunjithapatham, R., Buijs, M., Vossen, J. A., Tchernyshyov, I., Cole, R. N., Syed, L. H., Rao, P. P., Ota, S., et al. (2009) · PubMed · Cited by 121 · see citing works

Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line.

Nakashima, R. A., Paggi, M. G., Scott, L. J., & Pedersen, P. L. (1988) · PubMed · Cited by 114 · see citing works

Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma

Kim, W. K., Yoon, J., Jeong, J. M., Cheon, G. J., Lee, T. S., Yang, J. I., Park, S.-C., & Lee, H.-S. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0115 · Cited by 113 · see citing works

Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells

Nakano, A., Tsuji, D., Miki, H., Cui, Q., Sayed, S. M. E., Ikegame, A., Oda, A., Amou, H., Nakamura, S., Harada, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027222 · Cited by 106 · see citing works

Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-Bromopyruvate Propyl Ester

Tang, Z., Yuan, S., Hu, Y., Zhang, H., Wu, W., Zeng, Z.-L., Yang, J., Yun, J., Xu, R., & Huang, P. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9420-9 · Cited by 92 · see citing works

Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor

Cao, X., Bloomston, M., Zhang, T., Frankel, W. L., Jia, G., Wang, B., Hall, N. C., Koch, R. M., Cheng, H., Knopp, M. V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1607 · Cited by 83 · see citing works

Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate

Ko, Y. H., & McFadden, B. A. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90273-2 · Cited by 81 · see citing works

Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus

Presek, P., Reinacher, M., & EIGENBRODT, E. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81014-7 · Cited by 79 · see citing works

Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study

Sayed, S. M. E., Mohamed, W. G., Seddik, M.-A. H., Ahmed, A.-S. A., Mahmoud, A. G., Amer, W. H., Nabo, M. M. H., Hamed, A., Ahmed, N. S., & Abd-Allah, A. A.-R. (2014) · 癌症：英文版 · doi:10.5732/cjc.013.10111 · Cited by 77 · see citing works

The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside

Azevedo‐Silva, J., Queirós, O., Baltazar, F., Ułaszewski, S., Goffeau, A., Ko, Y. H., Pedersen, P. L., Preto, A., & Casal, M. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9670-z · Cited by 74 · see citing works

How do mutated oncogenes and tumor suppressor genes cause cancer?

Grandér, D. (1998) · Medical Oncology · doi:10.1007/bf02787340 · Cited by 73 · see citing works

Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3‐bromopyruvate

Thangaraju, M., Karunakaran, S. K., Itagaki, S., Gopal, E., Elangovan, S., Prasad, P. D., & Ganapathy, V. (2009) · Cancer · doi:10.1002/cncr.24532 · Cited by 70 · see citing works

Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer

Chapiro, J., Sur, S., Savic, L. J., Ganapathy‐Kanniappan, S., Reyes, J., Durán, R., Chettiar, S. T., Moats, C. R., Lin, M., Luo, W., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1271 · Cited by 61 · see citing works

Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent

Dell’Antone, P. (2009) · Medicinal Chemistry · doi:10.2174/157340609790170551 · Cited by 59 · see citing works

Suppression of Tumor Energy Supply by Liposomal Nanoparticle-Mediated Inhibition of Aerobic Glycolysis

Zhang, Y., Wei, J., Xu, J., Leong, W. S., Liu, G., Ji, T., Cheng, Z., Wang, J., Lang, J., Zhao, Y., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16685 · Cited by 59 · see citing works

Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma

Wicks, R. T., Azadi, J. R., Mangraviti, A., Zhang, I., Hwang, L. S., Joshi, A. D., Bow, H. C., Hütt-Cabezas, M., Martin, K. L., Rudek, M. A., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou143 · Cited by 57 · see citing works

The Expression of Glyceraldehyde-3-Phosphate Dehydrogenase Associated Cell Cycle (GACC) Genes Correlates with Cancer Stage and Poor Survival in Patients with Solid Tumors

Wang, D., Moothart, D. R., Lowy, D. R., & Qian, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061262 · Cited by 57 · see citing works

Glucose catabolism in African trypanosomes. Evidence that the terminal step is catalyzed by a pyruvate transporter capable of facilitating uptake of toxic analogs.

Barnard, J. P., Reynafarje, B., & Pedersen, P. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53743-1 · Cited by 54 · see citing works

3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines

Qin, J.-Z., Xin, H., & Nickoloff, B. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.126 · Cited by 52 · see citing works

Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells

Kwiatkowska, E., Wojtala, M., Gajewska, A., Soszyński, M., Bartosz, G., & Sadowska‐Bartosz, I. (2015) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-015-9637-5 · Cited by 50 · see citing works

Advances in Mycobacterial Isocitrate Lyase Targeting and Inhibitors

Krátký, M., & Vinšová, J. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712804485782 · Cited by 49 · see citing works

Intraarterial Therapy with a New Potent Inhibitor of Tumor Metabolism (3-bromopyruvate): Identification of Therapeutic Dose and Method of Injection in an Animal Model of Liver Cancer

Vali, M., Liapi, E. A., Kowalski, J., Hong, K. K., Khwaja, A. A., Torbenson, M. S., Georgiades, C. S., & Geschwind, J.-F. H. (2007) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2006.10.019 · Cited by 48 · see citing works

Human Hepatocellular Carcinoma in a Mouse Model: Assessment of Tumor Response to Percutaneous Ablation by Using Glyceraldehyde-3-Phosphate Dehydrogenase Antagonists

Ganapathy‐Kanniappan, S., Kunjithapatham, R., Torbenson, M. S., Rao, P. P., Carson, K. A., Buijs, M., Vali, M., & Geschwind, J.-F. H. (2012) · Radiology · doi:10.1148/radiol.11111569 · Cited by 47 · see citing works

The Specific Role of O 6 -Methylguanine-DNA Methyltransferase Inhibitors in Cancer Chemotherapy

Sun, G., Zhao, L., Zhong, R., & Peng, Y. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0069 · Cited by 47 · see citing works

Advances in Mycobacterial Isocitrate Lyase Targeting and Inhibitors

Krátký, M., & Vinšová, J. (2012) · Current Medicinal Chemistry · doi:10.2174/0929867311209066126 · Cited by 45 · see citing works

3‐bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes

Ehrke, E., Arend, C., & Dringen, R. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23474 · Cited by 44 · see citing works

Bromopyruvate as an active-site-directed inhibitor of the pyruvate dehydrogenase multienzyme complex from Escherichia coli

Lowe, P. N., & Perham, R. N. (1984) · Biochemistry · doi:10.1021/bi00296a015 · Cited by 43 · see citing works

3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system

Valenti, D., Vacca, R. A., & Lidia de, B. A. R. I. (2015) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-015-9631-y · Cited by 42 · see citing works

The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma

Levy, A. G., Zage, P. E., Akers, L. J., Ghisoli, M. L., Chen, Z., Fang, W., Kannan, S., Graham, T. C., Zeng, L., Franklin, A. R. K., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9551-y · Cited by 40 · see citing works

Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines

Attia, Y. M., El-Abhar, H. S., Marzabani, M. M. A., & Shouman, S. A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1850-4 · Cited by 40 · see citing works

Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate: In Vivo Investigation in Normal Rabbit Model

Chang, J. M., Chung, J. W., Jae, H. J., Eh, H., Son, K. R., Lee, K. C., & Park, J. H. (2006) · Academic Radiology · doi:10.1016/j.acra.2006.09.059 · Cited by 39 · see citing works

The inactivation of succinate dehydrogenase by bromopyruvate

Sanborn, B. M., Felberg, N. T., & Hollocher, T. C. (1971) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(71)90055-6 · Cited by 39 · see citing works

Aerosolized 3-Bromopyruvate Inhibits Lung Tumorigenesis without Causing Liver Toxicity

Zhang, Q., Pan, J., North, P. E., Yang, S., Lubet, R. A., Wang, Y., & You, M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0338 · Cited by 38 · see citing works

Regulation of Death Induction and Chemosensitizing Action of 3-Bromopyruvate in Myeloid Leukemia Cells: Energy Depletion, Oxidative Stress, and Protein Kinase Activity Modulation

Calviño, E., Estañ, M. C., Sànchez‐Martìn, C., Brea, R., de Blas, E., Boyano-Adánez, M. D. C., Rial, E., & Aller, P. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.206714 · Cited by 37 · see citing works

Antitumor and chemosensitizing action of 3-bromopyruvate: Implication of deregulated metabolism

Yadav, S., Pandey, S. K., Kumar, A., Kujur, P. K., Singh, R. P., & Singh, S. M. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.015 · Cited by 37 · see citing works

Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis

Amiji, M. M., Gandham, S. K., Talekar, M., & Singh, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s82818 · Cited by 34 · see citing works

The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance In Vitro and In Vivo Derived from Human Breast MCF-7/ADR Cells

Wu, L., Xu, J., Yuan, W., Wu, B., Wang, H., Liu, G., Wang, X., Du, J., & Cai, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112132 · Cited by 34 · see citing works

Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma

Bean, J. F., Qiu, Y.-Y., Yu, S., Clark, S. H., Chu, F., & Madonna, M. B. (2014) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2014.01.037 · Cited by 34 · see citing works

Bromopyruvate inactivation of glutamate apodecarboxylase. Kinetics and specificity.

Fonda, M. L. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33949-2 · Cited by 33 · see citing works

Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience

Sayed, S. M. E. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s170564 · Cited by 33 · see citing works

Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells

Xiao, H., LI, S., Zhang, D., Liu, T., Yu, M., & Wang, F. (2012) · Oncology Reports · doi:10.3892/or.2012.2085 · Cited by 31 · see citing works

3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells.

Messeder, D. J., & Moreira-Pacheco, F. (2016) · PubMed · Cited by 31 · see citing works

Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma

Niedźwiecka, K., Dyląg, M., Augustyniak, D., Majkowska-Skrobek, G., Cal, M., Ko, Y. H., Pedersen, P. L., Goffeau, A., & Ułaszewski, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11592 · Cited by 31 · see citing works

The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view

Sayed, S. M. E., Baghdadi, H., Zolaly, M. A., Almaramhy, H. H., Ayat, M., & Donki, J. G. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.014 · Cited by 31 · see citing works

Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis

Chong, D., Ma, L., Liu, F., Zhang, Z., Zhao, S., Huo, Q., Zhang, P., Zheng, H., & Liu, H. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000517 · Cited by 29 · see citing works

Inactivation of H+-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent

Dell’Antone, P. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.043 · Cited by 28 · see citing works

Anticancer agent 3-bromopyruvic acid forms a conjugate with glutathione

Sadowska‐Bartosz, I., Szewczyk, R., Jaremko, Ł., Jaremko, M., & Bartosz, G. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.11.007 · Cited by 28 · see citing works

The Potential of Combi-Molecules with DNA-Damaging Function as Anticancer Agents

Sun, G., Fan, T., Zhao, L., Zhou, Y., & Zhong, R. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0229 · Cited by 28 · see citing works

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells

Lee, M., Jo, A., Lee, S., Kim, J. B., Chang, Y., Nam, J. Y., Cho, H., Cho, Y. Y., Cho, E. J., Lee, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174271 · Cited by 28 · see citing works

3-Bromopyruvate: A novel antifungal agent against the human pathogen Cryptococcus neoformans

Dyląg, M., Lis, P., Niedźwiecka, K., Ko, Y. H., Pedersen, P. L., Goffeau, A., & Ułaszewski, S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.125 · Cited by 27 · see citing works

Deregulation of glyceraldehyde-3-phosphate dehydrogenase expression during tumor progression of human cutaneous melanoma.

Ramos, D., Pellín-Carcelén, A., Agustí, J., Murgui, A., Jordá, E., Pellı́n, A., & Monteagudo, C. C. (2015) · PubMed · Cited by 27 · see citing works

The antitumor agent 3-bromopyruvate has a short half-life at physiological conditions

Glick, M., Biddle, P. H., Jantzi, J., Weaver, S., & Schirch, D. M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.066 · Cited by 26 · see citing works

3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5

Chen, Y., Wei, L., Zhang, X., Liu, X., Chen, Y., Zhang, S., Zhou, L., Li, Q., Pan, Q., Zhao, S., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6644 · Cited by 26 · see citing works

The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy

Guohui, S., Lijiao, Z., & Ru-gang, Z. (2015) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150824160421 · Cited by 25 · see citing works

Effects of Bromopyruvate on the Control and Catalytic Properties of Glutamate Dehydrogenase

Baker, J. P., & Rabin, B. R. (1969) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1969.tb00753.x · Cited by 25 · see citing works

Abstract 2673: Idelalisib has activity at clinically achievable drug concentrations in a subset of ABC and GCB diffuse large B-cell lymphoma and transformed follicular lymphoma cell lines

Liu, J. Y., Kenney, T., Butterworth, L., Kashishian, A., Meadows, S. A., Peng, Y., Li, L., Keegan, K. S., Quéva, C., & Tannheimer, S. L. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-2673 · Cited by 24 · see citing works

Investigations on the Effect of O6-Benzylguanine on the Formation of dG-dC Interstrand Cross-Links Induced by Chloroethylnitrosoureas in Human Glioma Cells Using Stable Isotope Dilution High-Performance Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry

Sun, G., Zhao, L., Fan, T., Li, S., & Zhong, R. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500143b · Cited by 24 · see citing works

3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells

Chiasserini, D., Davidescu, M., Orvietani, P. L., Susta, F., Macchioni, L., Petricciuolo, M., Castigli, E., Roberti, R., Binaglia, L., & Corazzi, L. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.11.013 · Cited by 24 · see citing works

Enhanced Antitumor Activity of 3-Bromopyruvate in Combination with Rapamycin In Vivo and In Vitro

Zhang, Q., Pan, J., Lubet, R. A., Komas, S. M., Kalyanaraman, B., Wang, Y., & You, M. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0142 · Cited by 23 · see citing works

Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat model

Kunjithapatham, R., Geschwind, J.-F. H., Rao, P. P., Boronina, T. N., Cole, R. N., & Ganapathy‐Kanniappan, S. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-277 · Cited by 22 · see citing works

Silencing hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.

Peng, Q., Zhou, J., Zhou, Q. G., Pan, F., Zhong, D., & Liang, H. (2009) · PubMed · Cited by 22 · see citing works

Involvement of α-Cysteine-62 and β-Tryptophan-135 in Human Pyruvate Dehydrogenase Catalysis

Korotchkina, L. G., Ali, M. S., & Patel, M. S. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1364 · Cited by 20 · see citing works

3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis

Jagielski, T., Niedźwiecka, K., Roeske, K., & Dyląg, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00375 · Cited by 20 · see citing works

Effect of 3-Bromopyruvate and Atovaquone on Infection during In Vitro Interaction of Toxoplasma gondii and LLC-MK2 Cells

de Lima, L. P. O., Seabra, S. H., Carneiro, H., & Barbosa, H. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00337-15 · Cited by 18 · see citing works

3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells.

Liu, Z., Sun, Y., Hong, H., Zhao, S., Zou, X., Ma, R., Jiang, C., Wang, Z. P., Li, H., & Liu, H. (2015) · Europe PMC (PubMed Central) · Cited by 18 · see citing works

Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies

Icard, P., Zhang, X., Lemoisson, E., Louis, M.-H., Allouche, S., Lincet, H., & Poulain, L. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9415-6 · Cited by 17 · see citing works

Identification of the bromopyruvate-sensitive glutamate within the active site of 2-keto-3-deoxygluconate-6-P aldolase

Meloche, H. P., Monti, C. T., & Hogue‐Angeletti, R. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)90746-5 · Cited by 16 · see citing works

A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells

Chen, T. C., Yu, J., Nouri-Nigjeh, E., Wang, W., Myint, P. T., Zandi, E., Hofman, F. M., & Schönthal, A. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.015 · Cited by 16 · see citing works

Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: Implication of niche dependent differential roles of macrophages

Yadav, S., Pandey, S. K., Goel, Y., Kujur, P. K., Maurya, B. N., Verma, A. K., Kumar, A., Singh, R. P., & Singh, S. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.149 · Cited by 16 · see citing works

18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node‐negative non‐small cell lung cancer

Takahashi, Y., Suzuki, S., Matsutani, N., & Kawamura, M. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12978 · Cited by 16 · see citing works

Antiglycolytic Therapy Combined with an Image-guided Minimally Invasive Delivery Strategy for the Treatment of Breast Cancer

Buijs, M., Wijlemans, J. W., Kwak, B. K., Ota, S., & Geschwind, J.-F. H. (2013) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2013.01.013 · Cited by 15 · see citing works

Candidate cancer drug suspected after death of three patients at an alternative medicine clinic

Feldwisch‐Drentrup, H. (2016) · Science · doi:10.1126/science.aah7192 · Cited by 15 · see citing works

Antitumor action of 3-bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria-dependent tumor cell death

Yadav, S., Kujur, P. K., Pandey, S. K., Goel, Y., Maurya, B. N., Verma, A. K., Kumar, A., Singh, R. P., & Singh, S. M. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.12.004 · Cited by 15 · see citing works

Affinity labels for the anion-binding site in ovotransferrin

Bailey, C. T., Patch, M. G., & Carrano, C. J. (1988) · Biochemistry · doi:10.1021/bi00417a012 · Cited by 14 · see citing works

Valproate sensitizes human glioblastoma cells to 3-bromopyruvate-induced cytotoxicity

Ishiguro, Y., Kobayashi, M., Ideno, M., Narumi, K., Furugen, A., & Iseki, K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.08.039 · Cited by 14 · see citing works

Modification of yeast pyruvate kinase by an active site-directed reagent, bromopyruvate.

Yun, S.-I., & Suelter, C. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37727-x · Cited by 13 · see citing works

Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma

Ding, J., Chen, Y.-L., Zhou, S., & Zhao, K. (2018) · Journal of International Medical Research · doi:10.1177/0300060518804375 · Cited by 13 · see citing works

Oxidative Phosphorylation and Cancer: The Ongoing Warburg Hypothesis

Ristow, M., & Cuezva, J. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_1 · Cited by 11 · see citing works

ABCB1-overexpressing MDCK-II cells are hypersensitive to 3-bromopyruvic acid

Sadowska‐Bartosz, I., Grębowski, J., Kępka, E., Studzian, M., Bartosz, G., & Pułaski, Ł. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.012 · Cited by 11 · see citing works

The carbonyl reactivity of 3-bromopyruvate and related compounds

Fischer, G. S., Sieber, M., & Schellenberger, A. (1982) · Bioorganic Chemistry · doi:10.1016/0045-2068(82)90039-6 · Cited by 10 · see citing works

Modification of Human Erythrocyte Pyruvate Kinase by an Active Site-directed Reagent: Bromopyruvate

Açan, N. L., & Özer, N. (2001) · Journal of enzyme inhibition · doi:10.1080/14756360109162395 · Cited by 10 · see citing works

Erratum to: Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies

Icard, P., Zhang, X.-D., Lemoisson, E., Louis, M.-H., Allouche, S., Lincet, H., & Poulain, L. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9484-6 · Cited by 9 · see citing works

Final results of a prematurely discontinued Phase 1/2 study of eniluracil with escalating doses of 5-fluorouracil administered orally in patients with advanced hepatocellular carcinoma

Lopes, G. D. L., Jr., Dicksey, J. S., Peters, W. P., Palalay, M. P., & Chang, A. Y. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1588-x · Cited by 7 · see citing works

[Laboratory markers of melanoma progression].

Bánfalvi, T., Edesné, M. B., Gergye, M., Udvarhelyi, N., Orosz, Z., Gilde, K., Kremmer, T., Ottó, S., & Tı́már, J. (2003) · PubMed · Cited by 5 · see citing works

Synergistic in-vitro effects of combining an antiglycolytic, 3-bromopyruvate, and a bromodomain-4 inhibitor on U937 myeloid leukemia cells

Kapp, N., Stander, X. X., & Stander, B. A. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000613 · Cited by 5 · see citing works

The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH

Silva, J. S. A. L., Queirós, O., Ribeiro, A., Baltazar, F., Young, K. H., Pedersen, P. L., Preto, A., & Casal, M. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.1042/bj20140921

Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy

Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 589 · see citing works

Stromal cells in the tumor microenvironment: accomplices of tumor progression?

Zhao, Y. F., Shen, M., Wu, L., Yang, H., Yao, Y., Yang, Q., Du, J., Liu, L., Li, Y., & Bai, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06110-6 · Cited by 443 · see citing works

A proteogenomic portrait of lung squamous cell carcinoma

Satpathy, S., Krug, K., Beltran, P. M. J., Savage, S. R., Petralia, F., Kumar‐Sinha, C., Dou, Y., Reva, B. A., Kane, M. H., Avanessian, S. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.016 · Cited by 377 · see citing works

Modulating Glycolysis to Improve Cancer Therapy

Chelakkot, C., Chelakkot, V. S., Shin, Y. K., & Song, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032606 · Cited by 378 · see citing works

Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy

Fendt, S., Frezza, C., & Erez, A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0844 · Cited by 320 · see citing works

Targeting the Warburg Effect in Cancer: Where Do We Stand?

Barba, I., Carrillo-Bosch, L., & Seoane, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063142 · Cited by 248 · see citing works

Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters

Ciscato, F., Ferrone, L., Masgras, I., Laquatra, C., & Rasola, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094716 · Cited by 243 · see citing works

Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer

Varghese, E., Samuel, S. M., Líšková, A., Samec, M., Kubatka, P., & Büsselberg, D. (2020) · Cancers · doi:10.3390/cancers12082252 · Cited by 208 · see citing works

Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology

Yang, J., Griffin, A. S., Qiang, Z., & Ren, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01243-0 · Cited by 211 · see citing works

The roles of glucose metabolic reprogramming in chemo- and radio-resistance

Lin, J., Xia, L., Liang, J., Han, Y., Wang, H., Oyang, L., Tan, S., Tian, Y., Rao, S., Chen, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1214-z · Cited by 191 · see citing works

The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment

Zhou, D., Duan, Z.-L., Li, Z., Ge, F., Wei, R., & Kong, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1091779 · Cited by 168 · see citing works

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159 · see citing works

A highly annotated database of genes associated with platinum resistance in cancer

Huang, D., Savage, S. R., Calinawan, A. P., Lin, C., Zhang, B., Wang, P., Starr, T. K., Birrer, M. J., & Paulovich, A. G. (2021) · Oncogene · doi:10.1038/s41388-021-02055-2 · Cited by 149 · see citing works

Glycolysis, the sweet appetite of the tumor microenvironment

Kooshan, Z., Cárdenas-Piedra, L., Clements, J. A., & Batra, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217156 · Cited by 129 · see citing works

Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities

Meng, Y.-M., Jiang, X., Zhao, X., Meng, Q., Wu, S., Chen, Y., Kong, X., Qiu, X., Su, L., Huang, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26259-y · Cited by 124 · see citing works

Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation

Potęga, A. (2022) · Molecules · doi:10.3390/molecules27165252 · Cited by 119 · see citing works

Disrupting Circadian Rhythm via the PER1–HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer

Wang, J., Huang, Q., Hu, X., Zhang, S., Jiang, Y., Yao, G., Hu, K., Xu, X., Liang, B., Wu, Q., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1820 · Cited by 113 · see citing works

Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma

Duraj, T., Garcia‐Romero, N., Carrión-Navarro, J., Madurga, R., de Méndivil, A. O., Prat-Acín, R., García‐Cañamaque, L., & Ayuso‐Sacido, Á. (2021) · Cells · doi:10.3390/cells10020202 · Cited by 97 · see citing works

Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer

Yang, Y., Liu, Q., Wang, M., Li, L., Yu, Y. M., Pan, M., Hu, D., Chu, B., Qu, Y., & Qian, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01859-4 · Cited by 97 · see citing works

Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine

Wang, Q., Atluri, K., Tiwari, A. K., & Babu, R. J. (2023) · Pharmaceuticals · doi:10.3390/ph16030433 · Cited by 100 · see citing works

GLUT and HK: Two primary and essential key players in tumor glycolysis

Yadav, D., Yadav, A., Bhattacharya, S., Dagar, A., Kumar, V., & Rani, R. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.03.001 · Cited by 87 · see citing works

Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target

Zhao, J., Jin, D., Huang, M., Ji, J., Xu, X., Wang, F., Zhou, L., Bao, B., Jiang, F., Xu, W., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1416472 · Cited by 84 · see citing works

Metabolic tricks of cancer cells

Hönigová, K., Navrátil, J., Peltanová, B., Polanska, H. H., Raudenská, M., & Masařík, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188705 · Cited by 84 · see citing works

Targeting glycolysis in non-small cell lung cancer: Promises and challenges

Xu, J.-Q., Fu, Y.-L., Zhang, J., Zhang, K.-Y., Ma, J., Tang, J.-Y., Zhang, Z.-W., & Zhou, Z.-Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1037341 · Cited by 75 · see citing works

Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy

Tao, H., Zhong, X., Zeng, A., & Song, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1208870 · Cited by 73 · see citing works

Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors

Sun, X., Peng, Y., Zhao, J., Xie, Z., Lei, X., & Tang, G. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104891 · Cited by 65 · see citing works

Linking Metabolic Reprogramming, Plasticity and Tumor Progression

Shuvalov, O., Daks, A., Fedorova, O., Petukhov, A., & Barlev, N. (2021) · Cancers · doi:10.3390/cancers13040762 · Cited by 63 · see citing works

Ursolic Acid Inhibits Breast Cancer Metastasis by Suppressing Glycolytic Metabolism via Activating SP1/Caveolin-1 Signaling

Wang, S., Xu, C., Zhang, J., Li, J., Wang, N., Yang, B., Pan, B., Zheng, Y., Wang, X., Ou, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.745584 · Cited by 62 · see citing works

Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy

Kozal, K., Jóźwiak, P., & Krześlak, A. (2021) · Cancer Control · doi:10.1177/10732748211041243 · Cited by 63 · see citing works

Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities

Khan, M. A., Zubair, H., Anand, S., Srivastava, S. K., Singh, S., & Singh, A. P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.003 · Cited by 61 · see citing works

The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers

Chen, T. C., da Fonseca, C. O., Levin, D., & Schönthal, A. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122167 · Cited by 61 · see citing works

Canagliflozin, a SGLT-2 inhibitor, relieves ER stress, modulates autophagy and induces apoptosis in irradiated HepG2 cells

Abdel-Rafei, M. K., Thabet, N. M., Rashed, L. A., & Moustafa, E. M. (2021) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_963_19 · Cited by 57 · see citing works

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment

Aden, D., Sureka, N., Zaheer, S., Chaurasia, J. K., & Zaheer, S. (2024) · Immunology · doi:10.1111/imm.13871 · Cited by 54 · see citing works

β-Caryophyllene in the Essential Oil from Chrysanthemum Boreale Induces G1 Phase Cell Cycle Arrest in Human Lung Cancer Cells

Chung, K., Hong, J. Y., Lee, J., Lee, J., Park, J. Y., Choi, J., Park, H.-J., Hong, J., & Lee, K. (2019) · Molecules · doi:10.3390/molecules24203754 · Cited by 54 · see citing works

The extracellular lactate-to-pyruvate ratio modulates the sensitivity to oxidative stress-induced apoptosis via the cytosolic NADH/NAD+ redox state

Go, S., Kramer, T. T., Verhoeven, A. J., Elferink, R. P. J. O., & Chang, J. (2020) · APOPTOSIS · doi:10.1007/s10495-020-01648-8 · Cited by 53 · see citing works

Targeting glycolysis for cancer therapy using drug delivery systems

Huang, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.003 · Cited by 51 · see citing works

The dual role of DNA repair protein MGMT in cancer prevention and treatment

Bai, P., Fan, T., Sun, G., Wang, X., Zhao, L., & Zhong, R. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103449 · Cited by 50 · see citing works

3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells

Sun, X., Sun, G., Huang, Y., Hao, Y., Tang, X., Zhang, N., Zhao, L., Zhong, R., & Peng, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113988 · Cited by 48 · see citing works

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics

Pal, S., Sharma, A. K., Mathew, S. P., & Jaganathan, B. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955476 · Cited by 49 · see citing works

Phytochemicals modulate cancer aggressiveness: A review depicting the anticancer efficacy of dietary polyphenols and their combinations

Mitra, T., & Bhattacharya, R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29703 · Cited by 46 · see citing works

Raman optical identification of renal cell carcinoma via machine learning

He, C., Wu, X., Zhou, J., Chen, Y., & Ye, J. (2021) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2021.119520 · Cited by 46 · see citing works

Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment

Jiang, J., & Ying, H. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02457-4 · Cited by 47 · see citing works

Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation

Wang, T., Zhang, M., Khan, M. T., Li, J., Wu, X. J., Ma, T., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115956 · Cited by 45 · see citing works

Cultivation of Cells in a Physiological Plasmax Medium Increases Mitochondrial Respiratory Capacity and Reduces Replication Levels of RNA Viruses

Golikov, M. V., Karpenko, I. L., Lipatova, A. V., Ivanova, O. N., Тимофеевна, Ф. И., Филиппович, Л. В., Zakirova, N. F., Leonova, O. G., Попенко, В. И., Bartosch, B., et al. (2021) · Antioxidants · doi:10.3390/antiox11010097 · Cited by 45 · see citing works

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma

Wu, S., Kuang, H., Ke, J., Pi, M., & Yang, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.591342 · Cited by 42 · see citing works

Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition

Linden, C. V., Corbet, C., Bastien, E., Martherus, R., Guilbaud, C., Petit, L., Wauthier, L., Loriot, A. E., Smet, C. D., & Féron, O. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109202 · Cited by 46 · see citing works

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance

Lei, P., Wang, W., Sheldon, M., Sun, Y., Yao, F., & Ma, L. (2023) · Cancers · doi:10.3390/cancers15133390 · Cited by 40 · see citing works

3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model

Yu, H., Zhu, J., Chang, L., Liang, C. Y., Li, X., & Wang, W. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119206 · Cited by 40 · see citing works

2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation

Sun, X., Fan, T., Sun, G., Zhou, Y., Huang, Y., Zhang, N., Zhao, L., Zhong, R., & Peng, Y. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115029 · Cited by 39 · see citing works

Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2

Zheng, Y., Zhan, Y., Zhang, Y., Zhang, Y., Liu, Y., Xie, Y., Sun, Y., Qian, J., Ding, Y., Ding, Y., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06009-2 · Cited by 37 · see citing works

Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review

Wang, Q., Liu, J., Chen, Z., Zheng, J., Wang, Y., & Dong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116021 · Cited by 39 · see citing works

Antitumor Effect of Pyrogallol via miR-134 Mediated S Phase Arrest and Inhibition of PI3K/AKT/Skp2/cMyc Signaling in Hepatocellular Carcinoma

Ahn, H., Im, E., Lee, D., Lee, H., Jung, J. H., & Kim, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163985 · Cited by 37 · see citing works

The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells

Cal, M., Matyjaszczyk, I., Litwin, I., Augustyniak, D., Ogórek, R., Ko, Y. H., & Ułaszewski, S. (2020) · Cells · doi:10.3390/cells9051161 · Cited by 37 · see citing works

Pathogenesis and Clinical Management of Uterine Serous Carcinoma

Zhang, L., Kwan, S., Wong, K., Soliman, P. T., Lu, K. H., & Mok, S. C. (2020) · Cancers · doi:10.3390/cancers12030686 · Cited by 36 · see citing works

Exosome membrane-sheathed and multi-stimuli-responsive MnO2 nanoparticles with self-oxygenation and energy depletion abilities potentiate the sonodynamic therapy of hypoxic tumors

Hoang, Q. T., Cao, T. G. N., Kang, S. J., Lee, M., Kang, J. H., Park, H. S., Kim, J., Bhang, S. H., Ko, Y. T., Rhee, W. J., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.144871 · Cited by 34 · see citing works

Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities

Liu, Q., Bode, A. M., Chen, X., & Luo, X. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189023 · Cited by 28 · see citing works

Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development

Feng, J., Byrne, N. M., Al-Jamal, W. T., & Coulter, J. A. (2019) · Cancers · doi:10.3390/cancers11121989 · Cited by 28 · see citing works

Covalent inhibitors of GAPDH: From unspecific warheads to selective compounds

Galbiati, A., Zana, A., & Conti, P. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112740 · Cited by 27 · see citing works

Metabolic memory underlying minimal residual disease in breast cancer

Shechter, K. R., Kafkia, E., Zirngibl, K., Gawrzak, S., Alladin, A., Machado, D., Lüchtenborg, C., Sévin, D. C., Brügger, B., Patil, K. R., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010141 · Cited by 25 · see citing works

Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma

Tan, W.-Q., Yuan, L., Wu, X.-Y., He, C.-G., Zhu, S.-C., & Ye, M. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210272 · Cited by 26 · see citing works

Antineoplastic Properties by Proapoptotic Mechanisms Induction of Inula viscosa and Its Sesquiterpene Lactones Tomentosin and Inuviscolide

Migheli, R., Virdis, P., Galleri, G., Arru, C., Lostia, G., Coradduzza, D., Muroni, M. R., Pintore, G., Podda, L., Fozza, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112739 · Cited by 25 · see citing works

Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma

Kanwore, K., Kanwore, K., Adzika, G. K., Abiola, A. A., Guo, X., Kambey, P. A., Xia, Y., & Gao, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831636 · Cited by 25 · see citing works

Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis

Ahmed, S., Mahony, C. B., Torres, A., Murillo‐Saich, J., Kemble, S., Cedeño, M., John, P. C. L., Bhatti, A., Croft, A. P., & Gumá, M. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03161-0 · Cited by 25 · see citing works

Mechanisms of Long Non-Coding RNAs in Biological Characteristics and Aerobic Glycolysis of Glioma

Zhao, N., Zhang, J., Zhao, Q. C., Chen, C., & Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011197 · Cited by 25 · see citing works

Novel strategies to overcome chemoresistance in human glioblastoma

Tang, Q., Ren, T., Bai, P., Wang, X., Zhao, L., Zhong, R., & Sun, G. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116588 · Cited by 23 · see citing works

Energy Metabolic Plasticity of Colorectal Cancer Cells as a Determinant of Tumor Growth and Metastasis

Reinsalu, L., Puurand, M., Chekulayev, V. A., Miller, S., Shevchuk, I. N., Tepp, K., Rebane-Klemm, E., Timohhina, N., Terasmaa, A., & Käämbre, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698951 · Cited by 23 · see citing works

Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive

Li, Q., Chen, Q., Yang, X., Zhang, Y., Lv, L., Zhang, Z., Zeng, S., Lv, J., Liu, S., & Fu, B. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01241-y · Cited by 23 · see citing works

3‑Bromopyruvic acid regulates glucose metabolism by targeting the c‑Myc/TXNIP axis and induces mitochondria‑mediated apoptosis in TNBC cells

Li, J., Pan, J., Liu, Y., Luo, X.-H., Yang, C., Xiao, W.-F., Li, Q.-S., Yang, L., & Zhang, X. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11447 · Cited by 22 · see citing works

Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation

Sun, X., Sun, G., Huang, Y., Zhang, S., Tang, X., Zhang, N., Zhao, L., Zhong, R., & Peng, Y. (2020) · Toxicology · doi:10.1016/j.tox.2020.152413 · Cited by 22 · see citing works

20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells

Shuvalov, O., Kirdeeva, Y., Fefilova, E., Netsvetay, S., Zorin, M., Vlasova, Y., Fedorova, O., Daks, A., Parfenyev, S., & Barlev, N. (2023) · Metabolites · doi:10.3390/metabo13050656 · Cited by 21 · see citing works

Research Progress of Warburg Effect in Hepatocellular Carcinoma

Yang, Y., Gao, Y., Xiong, Y., Gong, Y., Lu, J., Zhang, Y., Wang, D., Liu, Z., & Shi, X. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2905178 · Cited by 22 · see citing works

Hereditary Leiomyomatosis and Renal Cell Cancer: Recent Insights Into Mechanisms and Systemic Treatment

Zhang, C., Li, L., Zhang, Y., & Zeng, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.686556 · Cited by 21 · see citing works

Validation of a Fast and Simple HPLC-UV Method for the Quantification of Adenosine Phosphates in Human Bronchial Epithelial Cells

Juárez-Facio, A. T., de Lagarde, V. M., Monteil, C., Vaugeois, J., Corbière, C., & Rogez-Florent, T. (2021) · Molecules · doi:10.3390/molecules26206324 · Cited by 21 · see citing works

Noncoding RNAs in the Glycolysis of Ovarian Cancer

Zhang, C., & Liu, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.855488 · Cited by 21 · see citing works

Arctium lappa Extract Suppresses Inflammation and Inhibits Melanoma Progression

Nascimento, B. A. C., Gardinassi, L. G., Silveira, I. M. G., Gallucci, M. G., Tomé, M. A., Oliveira, J. F. D., Moreira, M. D. R. D. A., Meirelles, A. F. G., Faccioli, L. H., Tefé‐Silva, C., et al. (2019) · Medicines · doi:10.3390/medicines6030081 · Cited by 21 · see citing works

Rotenone and 3-bromopyruvate toxicity impacts electrical and structural cardiac remodeling in rats

Zhan, C., Liu, G., Li, J., Li, G., Li, T., Zhao, H., Li, L., Yang, W. J., Bai, N., Zheng, M., et al. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.09.024 · Cited by 21 · see citing works

The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells

Petricciuolo, M., Davidescu, M., Fettucciari, K., Gatticchi, L., Brancorsini, S., Roberti, R., Corazzi, L., & Macchioni, L. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05741 · Cited by 20 · see citing works

Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate

Yadav, S., Pandey, S. K., Goel, Y., Temre, M. K., & Singh, S. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00728 · Cited by 19 · see citing works

Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate

Pieńkowska, N., Bartosz, G., Furdak, P., & Sadowska‐Bartosz, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020709 · Cited by 19 · see citing works

Green Propolis Compounds (Baccharin and p-Coumaric Acid) Show Beneficial Effects in Mice for Melanoma Induced by B16f10

Gastaldello, G. H., Cazeloto, A. C. V., Ferreira, J. C., Rodrigues, D. M., Bastos, J. K., Campo, V. L., Zoccal, K. F., & Tefé‐Silva, C. (2021) · Medicines · doi:10.3390/medicines8050020 · Cited by 19 · see citing works

Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer

Ma, R., Wu, Y., Li, S., & Yu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.654337 · Cited by 18 · see citing works

Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction

Gliozzo, J., Perlasca, P., Mesiti, M., Casiraghi, E., Vallacchi, V., Vergani, E., Frasca, M., Grossi, G., Petrini, A., Ré, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60235-8 · Cited by 17 · see citing works

Understanding the Hsp90 N-Terminal Dynamics: Structural and Molecular Insights into the Therapeutic Activities of Anticancer Inhibitors Radicicol (RD) and Radicicol Derivative (NVP-YUA922)

Magwenyane, A. M., Mhlongo, N. N., Lawal, M. M., Amoako, D. G., Somboro, A. M., Sosibo, S. C., Shunmugam, L., Khan, R. B., & Kumalo, H. M. (2020) · Molecules · doi:10.3390/molecules25081785 · Cited by 17 · see citing works

Tailor-made biotuner against colorectal tumor microenvironment to transfer harms into treasures for synergistic oncotherapy

Liang, J., Niu, M., Luo, G., Zhang, S., Huang, Q., Jin, X., Lu, Z., Chen, W., & Zhang, X. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101662 · Cited by 16 · see citing works

Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma

Xie, Y., Zhang, J., Li, M., Zhang, Y., Li, Q., Zheng, Y., & Wei, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.818868 · Cited by 16 · see citing works

Investigation and experimental validation of curcumin-related mechanisms against hepatocellular carcinoma based on network pharmacology

Yang, C., Li, Q., Ren, S., Chen, T., Zhai, B., Cheng, J., Shi, X., Song, L., Fan, Y., & Guo, D. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200038 · Cited by 16 · see citing works

3-Bromopyruvate-loaded bismuth sulfide nanospheres improve cancer treatment by synergizing radiotherapy with modulation of tumor metabolism

He, Y., Chen, H., Li, W., Xu, L. X., Yao, H., Cao, Y., Wang, Z., Zhang, L., Wang, D., & Zhou, D. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01970-8 · Cited by 15 · see citing works

Role of monocarboxylate transporter I/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells

Choi, M. C., Kim, S. K., Choi, Y. J., Choi, Y. J., Kim, S. T., Jegal, K. H., Lim, S., & Kang, K. W. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01474-x · Cited by 15 · see citing works

circ_BICD2 acts as a ceRNA to promote tumor progression and Warburg effect in oral squamous cell carcinoma by sponging miR-107 to enhance HK2.

Zhu, L.-S., Wang, Y., Li, R., Xu, X.-T., Li, K.-Y., & Zuo, C.-R. (2020) · PubMed Central · Cited by 15 · see citing works

Nanomaterials in cancer starvation therapy: pioneering advances, therapeutic potential, and clinical challenges

Tran, N. A., Moonshi, S. S., Lam, A. K.-Y., Lu, C. T., Vu, C. Q., Arai, S., & Ta, H. T. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10267-1 · Cited by 16 · see citing works

Energy Blocker Lonidamine Reverses Nimustine Resistance in Human Glioblastoma Cells through Energy Blockade, Redox Homeostasis Disruption, and O 6 -Methylguanine-DNA Methyltransferase Downregulation: In Vitro and In Vivo Validation

Huang, Y., Wang, P., Fan, T., Zhang, N., Zhao, L., Zhong, R., & Sun, G. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00085 · Cited by 14 · see citing works

Natural small molecule thymoquinone increases the chemosensitivity of glioblastoma to temozolomide through inhibiting Wnt/β-catenin signaling pathway to downregulate MGMT expression: In vitro and in vivo validation

Bai, P., Wang, P., Ren, T., Tang, Q., Lin, Z., Zhang, N., Zhao, L., 钟儒刚, & Sun, G. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116886 · Cited by 14 · see citing works

Circ_0039960 regulates growth and Warburg effect of breast cancer cells via modulating miR-1178/PRMT7 axis

Ma, W., Sun, X., Zhang, S., Chen, Z., & Yu, J. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101829 · Cited by 14 · see citing works

Study on the Function of the Inositol Polyphosphate Kinases Kcs1 and Vip1 of Candida albicans in Energy Metabolism

Peng, X., Yu, Q., Liu, Y., Ma, T., & Li, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.566069 · Cited by 13 · see citing works

Study of Endogen Substrates, Drug Substrates and Inhibitors Binding Conformations on MRP4 and Its Variants by Molecular Docking and Molecular Dynamics

Becerra, E., Aguilera-Durán, G., Berumen, L. C., Romo‐Mancillas, A., & García‐Alcocer, G. (2021) · Molecules · doi:10.3390/molecules26041051 · Cited by 13 · see citing works

Discovery of a novel Wnt inhibitor DK419: Reversing temozolomide resistance in glioblastoma by switching off Wnt/β-catenin signaling pathway to inhibit MGMT expression

Bai, P., Wang, P., Ren, T., Tang, Q., Zhang, N., Zhao, L., 钟儒刚, & Sun, G. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117411 · Cited by 12 · see citing works

l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations

Mota, P., Pires, R. F., Serpa, J., & Bonifácio, V. D. B. (2019) · Molecules · doi:10.3390/molecules24173111 · Cited by 12 · see citing works

An exosome-based nanoplatform for siRNA delivery combined with starvation therapy promotes tumor cell death through autophagy, overcoming refractory KRAS-mutated tumors and restoring cetuximab chemosensitivity

Xiang, Y., Liu, Q., Liu, K., Chen, L., Chen, F., Li, T., Li, S., Yu, Q., Lv, Q., & Xiang, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101732 · Cited by 11 · see citing works

The role of fatty acid desaturase 2 in multiple tumor types revealed by bulk and single-cell transcriptomes

Chen, E., Wang, C., Lv, H., & Yu, J. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01789-0 · Cited by 11 · see citing works

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Pei, J., Panina, S., & Kirienko, N. V. (2020) · Journal of Visualized Experiments · doi:10.3791/61295 · Cited by 11 · see citing works

Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug

Cardaci, S., Desideri, E., & Ciriolo, M. R. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9422-7 · Cited by 132 · see citing works

Anti-tumor effects and mechanisms of 3-bromopyruvate

Wu, S. (2009) · Zhongguo xin yao zazhi

Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent

Dell’Antone, P. (2009) · Medicinal Chemistry · doi:10.2174/157340609790170551 · Cited by 59 · see citing works

Novel therapy for malignant pleural mesothelioma based on anti-energetic effect: an experimental study using 3-Bromopyruvate on nude mice.

Zhang, X., Varin, E., Briand, M., Allouche, S., Heutte, N., Schwartz, L. H., Poulain, L., & Icard, P. (2009) · PubMed · Cited by 25 · see citing works

3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy

Ganapathy‐Kanniappan, S., Vali, M., Kunjithapatham, R., Buijs, M., Syed, L. H., Rao, P. P., Ota, S., Kwak, B. K., Loffroy, R., & Geschwind, J. F. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591427 · Cited by 126 · see citing works